Peer Review History

Original SubmissionJanuary 15, 2023
Decision Letter - Nelsensius Klau Fauk, Editor

PONE-D-23-01298Accessing mental health services for a child living with anxiety: Parents’ lived experience and recommendationsPLOS ONE

Dear Dr. Woodgate,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by 26/03/2023. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Nelsensius Klau Fauk, S.Fil., M., MHID, MSc, PhD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please update your submission to use the PLOS LaTeX template. The template and more information on our requirements for LaTeX submissions can be found at http://journals.plos.org/plosone/s/latex.

3. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

4. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

Please carefully address the reviewers' comments and resubmit.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Comments & suggestions to the authors

This study investigated the mental health services for a child living with anxiety, experienced by the parents. The Introduction clearly mentioned the seriousness of the problem and the rest of the paper have given detailed explanation of the study. However, some development could be used:

- The terminology for anxiety disorder should refer to ICD or DSM to make a clear distinction with anxiety as a symptom

- Do update the prevalence rate of anxiety disorder among adolescence as the one cited came from 2005 (WHO has more updated data)

- It is great to read the effort of the authors to explain/describe any methods used in this paper for the learning process of the readers

- What was the reporting guideline use by the authors?

- For the recruitment, the authors used the maximum variation technique of purposive sampling. Please elaborate more.

- Data collection: better if the data collection can be divided into two parts, to make a clearer understanding of the data collection process, between the semi-structured interviews and open-ended interviews. Was the AIDS-IV-C/P used for the parents or the children? What was the diagnostic criteria of it? Who did the interview for the diagnosis? (credentials) What were the purposes of each either semi-structured interviews and open-ended interviews? Also for the open-ended interviews, who did the interviews?

- How about the trustworthiness of the study?

- Data analysis: the first and second author did the data analysis. Describe the background of the authors, including gender and experience in qualitative study.

- Results: start with the process of the data analysis (how many codes into themes?) It is good as the authors have provided the coding tree into the tables.

- Overall, it is an interesting study for a better health care services and policy.

Reviewer #2: The paper reports very important findings. It is well written and easy to follow. I have only a few minor points on the method section to be addressed.

Please used the COREQ checklist to guide the report of the method section.

What is the qualification and research experience of the research assistant who conducted the interviews?

Who took the field notes during the interviews? Was it the RA/interviewer of somebody else? If the same person did the interviews and at the same time took notes, then any reflections of the difficult experience? It is not easy to interview and probe information from a participant if the interviewer has to take notes as well.

Who did the transcription of the audio recordings? Was it the RA or one of the authors? If it was not the RA, then how did you integrate the field notes into the transcripts?

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

We thank reviewers for their insightful comments. We believe our manuscript has benefited from your suggestions.

Reviewer #1: Comments & suggestions to the authors

This study investigated the mental health services for a child living with anxiety, experienced by the parents. The Introduction clearly mentioned the seriousness of the problem and the rest of the paper have given detailed explanation of the study. However, some development could be used:

- The terminology for anxiety disorder should refer to ICD or DSM to make a clear distinction with anxiety as a symptom

We have added a definition of anxiety disorders using the DSM-5. Please see track changes on p. 3, lines 66-72. We have added the new reference citation (see Reference List) and adjusted all reference citations accordingly (in-text and reference list).

- Do update the prevalence rate of anxiety disorder among adolescence as the one cited came from 2005 (WHO has more updated data)

We have provided information from a 2015 meta-analysis of the worldwide prevalence of mental disorders (including anxiety) for children and adolescents. Prior to this meta-analysis, there was no information as to a worldwide-pooled prevalence for this population specifically.

We checked WHO resources but found it challenging finding the reference citations provided (e.g, links no longer worked etc) or reference citations for anxiety disorders were not provided. For instance, for the following WHO resource: Mental health of adolescents (who.int) , although a reference citation is provided for the global prevalence of mental health conditions, the year of this source was not provided. Further, for emotional disorders including anxiety, no reference citation was provided. Thus, given the robust methodology used in the meta-analysis cited above, we decided to use that reference instead.

- It is great to read the effort of the authors to explain/describe any methods used in this paper for the learning process of the readers. What was the reporting guideline used by the authors?

We have used the COREQ checklist. Under the “Supporting Information” section of the manuscript, we note we are including an additional file labeled “S1 File. Consolidated criteria for reporting qualitative studies (COREQ) checklist”. Please see p. 36, line 914. Also see the additional file. The document highlights where in the manuscript (page number) checklist items are reported.

- For the recruitment, the authors used the maximum variation technique of purposive sampling. Please elaborate more.

We have noted that to facilitate capturing the complexity and variation of parental experience, we used purposive sampling and refer readers to an excellent reference citation that guided our decision regarding sampling strategy and sample size. Please see p. 7, lines 165-166

We have also added that to identify and select information-rich cases related to our phenomenon of interest (parents of a child living with anxiety), we recruited from both clinical and community settings. We then provide additional information as to recruitment approach in each setting (e.g., Clinical setting: through wait list of a specialized anxiety clinic; Community setting: youth centres, teen clinics, and schools). Please see p.7, lines 168-173.

- Data collection: better if the data collection can be divided into two parts, to make a clearer understanding of the data collection process, between the semi-structured interviews and open-ended interviews. Was the AIDS-IV-C/P used for the parents or the children? What was the diagnostic criteria of it? Who did the interview for the diagnosis? (credentials) What were the purposes of each either semi-structured interviews and open-ended interviews? Also for the open-ended interviews, who did the interviews?

We have divided that paragraph into two paragraphs. Please see p. 7, lines 180-198. We hope this facilitates readers’ understanding of the data collection process.

In the first paragraph we provide information about the semi-structured interviews. We note that: (1) the AIDS-IV-C/P was used with parents, (2) we used the Clinician Severity Rating (range -0-8; > 4 required to assign a diagnosis), and (3) that we used the ADIS-IV-C/P (purpose) to ensure our sample included parents of youth with a clinical diagnosis of anxiety. See p. 7, lines 183-189.

We also specify that our findings emerged from a larger study that explored the lived experience of Canadian youth living with anxiety for which both youth and their parents were interviewed. Please see p. 5, lines 131-132. In the Methods section, we highlight the questions that guided the open-ended interviews. Please see p. 8, lines 193-196.

We also note that the third author, a PhD trained research associate who has qualitative research training and experience administering the ADIS-IV-C/P conducted all interviews with guidance from the first author. Please see p. 8, lines 201-203.

- How about the trustworthiness of the study?

We have additional information about strategies used to enhance methodological rigour and trustworthiness. Please see p. 9 and 10, lines 234-242.

- Data analysis: the first and second author did the data analysis. Describe the background of the authors, including gender and experience in qualitative study.

We have added this information. Please see p.9, lines 231-233.

- Results start with the process of the data analysis (how many codes into themes?) It is good as the authors have provided the coding tree into the tables.

Yes, we have provided the coding tree in the tables. Please see Table 1 on p. 11, Table 2 on p.20, and Table 3 on p. 24.

- Overall, it is an interesting study for a better health care services and policy.

Reviewer #2:

-The paper reports very important findings. It is well written and easy to follow. I have only a few minor points on the method section to be addressed. Please used the COREQ checklist to guide the report of the method section.

We have used the COREQ checklist. Under the “Supporting Information” section of the manuscript, we note we are including an additional file labeled “S1 File. Consolidated criteria for reporting qualitative studies (COREQ) checklist”. Please see p. 36, line 914.

-What is the qualification and research experience of the research assistant who conducted the interviews?

We present this information on p. 8, lines 201-203.

-Who took the field notes during the interviews? Was it the RA/interviewer of somebody else? If the same person did the interviews and at the same time took notes, then any reflections of the difficult experience? It is not easy to interview and probe information from a participant if the interviewer has to take notes as well.

We note that field notes were recorded by the interviewer after each interview. Please see p. 8, lines 209-211.

-Who did the transcription of the audio recordings? Was it the RA or one of the authors? If it was not the RA, then how did you integrate the field notes into the transcripts?

Interviews were sent to a Professional Transcription Service used by the first author.

We have provided additional information as to how field notes and transcripts were integrated. Please see p.9, lines 226-229.

Attachments
Attachment
Submitted filename: ResponsetoReviewers.docx
Decision Letter - Nelsensius Klau Fauk, Editor

Accessing mental health services for a child living with anxiety: Parents’ lived experience and recommendations

PONE-D-23-01298R1

Dear Dr. Woodgate,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Nelsensius Klau Fauk, S.Fil., M., MHID, MSc, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Formally Accepted
Acceptance Letter - Nelsensius Klau Fauk, Editor

PONE-D-23-01298R1

Accessing mental health services for a child living with anxiety: Parents’ lived experience and recommendations

Dear Dr. Woodgate:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Nelsensius Klau Fauk

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .